Pembrolizumab 사용과 관련된 자가면역뇌염 1예
An Autoimmune Encephalitis Case Associated with Pembrolizumab Use
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Immune checkpoint inhibitors may be associated with various adverse events, including encephalitis. Here, we report a case of encephalopathy associated with pembrolizumab therapy. A 60-year-old male diagnosed with cholangiocarcinoma with peritoneal seeding presented altered mentality and cognitive function after using pembrolizumab. Electroencephalogram showed mild diffuse cerebral dysfunction. Cerebrospinal fluid (CSF) study showed no evidence of infection or autoimmune disease and no paraneoplastic antibody was detected from CSF and serum. After high-dose methylprednisolone intravenous infusion, patient’s mentality was fully recovered
Abstract
Immune checkpoint inhibitors may be associated with various adverse events, including encephalitis. Here, we report a case of encephalopathy associated with pembrolizumab therapy. A 60-year-old male diagnosed with cholangiocarcinoma with peritoneal seeding presented altered mentality and cognitive function after using pembrolizumab. Electroencephalogram showed mild diffuse cerebral dysfunction. Cerebrospinal fluid (CSF) study showed no evidence of infection or autoimmune disease and no paraneoplastic antibody was detected from CSF and serum. After high-dose methylprednisolone intravenous infusion, patient’s mentality was fully recovered
참고문헌 (10)
- Pramod Darvin, "Immune checkpoint inhibitors: recent progress and potential biomarkers", Experimental and Molecular Medicine, 50, pp.1~11 (2018), 생화학분자생물학회
- Cuzzubbo S, "Neurological adverse events associated with immune checkpoint inhibitors : review of the literature", Eur J Cancer, 73, pp.1~8 (2017)
- Feng S, "Pembrolizumab-induced encephalopathy : a review of neurological toxicities with immune checkpoint inhibitors", J Thorac Oncol, 12, pp.1626~1635 (2017)
- Schneider S, "PD-1checkpoint inhibitor associated autoimmune encephalitis", Case Rep Oncol, 10, pp.473~478 (2017)
- Spain L, "Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma : a single centre experience and review of the literature", Ann Oncol, 28, pp.377~385 (2017)
- Zimmer L, "Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy", Eur J Cancer, 60, pp.210~225 (2016)
- Graus F, "A clinical approach to diagnosis of autoimmune encephalitis", Lancet Neurol, 15, pp.391~404 (2016)
- Graus F, "Updated diagnostic criteria for paraneoplastic neurologic syndromes", Neurol Neuroimmunol Neuroinflamm, 8, pp.e1014~ (2021)
- Rahman SU, "Paraneoplastic syndromes in cholangiocarcinoma", World J Hepatol, 12, pp.897~907 (2020)
- Doja A, "Pediatric Epstein-Barr virus-associated encephalitis : 10-year review", J Child Neurol, 21, pp.384~391 (2006)